Document Classification

Section Type: METHODS

Text: Two hundred and eighty patients were randomized to receive 1) MET + dexamethasone (DEX) (10 mg * 4 and 2 mg * 1, respectively, orally), 2) TRO (5 mg * 1, orally), 3) TRO + MET (5 mg * 1 and 10 mg * 2, respectively, orally), 4) TRO + MET + DEX (5 mg * 1, 10 mg * 2, and 2 mg * 1, respectively, orally), 5) CHL + DEX (25 mg * 2 and 2 mg * 1, respectively, orally), 6) TRO + CHL (5 mg * 1 and 12. 5 mg * 2, respectively, orally), or 7) TRO + CHL + DEX (5 mg * 1, 12. 5 mg * 2, and 2 mg * 1, respectively, orally).